Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. This trial aims for a comparison of the efficacy and
safety of Insulin Aspart, given in a fixed or in a flexible supplementary insulin therapy,
with or without Insulin Detemir plus Metformin, if needed, in subjects with type 2 diabetes.